
Colgate Palmolive (India) Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here
Posted by : sachet | Wed Jan 28 2026

Click and Sign Up to Get Live Updates on Q3 Results
Colgate Palmolive (India) Q3 results FY26 are scheduled to be announced on 29th January 2026. Financial analysts anticipate an increase in revenue due to higher sales and a significant rise in PAT.
Colgate Palmolive (India) Q3 Results 2026 Preview
- Colgate Palmolive (India)’s revenue is expected to be in the range of ₹1,461.84 crore, a 9.71% YoY decrease.
- Profit After Tax, or PAT, is projected to fall by 18.29% YoY.
- Colgate Palmolive (India)’s EBITDA is expected to fall to ₹413.23 crore.
- Net profit is ₹322.78 crore, a fall 18.29% YoY
Colgate Palmolive (India) Share Performance
- Over the past six months, Colgate Palmolive (India )’s share price has fallen by 2.39% to ₹2,153.10.
- Moreover, over the past year, the stock has decreased by 19.64%.
- Despite this weak short-term performance, Colgate Palmolive (India )’s stock has delivered a financially sound 34.29% return over the past 5 years.
- As of 28th January 2026, the stock traded at ₹2,153.10 per share.
Key Factors to Watch for Colgate Palmolive (India) Q3 Results FY26
- Revenue & volume growth: Trend in net sales amid soft demand and prior GST‑linked disruptions in oral care channels.
- Profitability & margins: PAT and EBITDA margin performance relative to last year’s level and sequential improvement.
- Urban vs rural demand: Recovery in urban consumption and strength in rural markets influencing overall demand.
- Premiumisation & product mix: Traction in premium toothpaste ranges and new innovations driving higher‑value sales.
- Marketing & brand investments: Advertising and promotional spend aimed at supporting volume amid competition.
Final Thoughts
Colgate Palmolive (India) will announce its Q3 FY26 results on 29th January 2026. Analysts expect 9.71% YoY revenue growth, a 18.29% fall in PAT, and a 9.30% fall in EBITDA. Colgate-Palmolive (India) focuses recovery in organic demand and revenue growth after GST disruption, premiumisation and new product traction, while margins and urban sales trends guide profitability outlook.
Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.
Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!
Recent Articles
Top 10 Penny Stocks in India | Penny Stocks to Buy in 2026
Best Stocks to Buy Today: Explore Best Stocks With Expected Trends
Milky Mist Dairy Foods IPO Details: Everything You Should Know about
Karbonsteel Engineering IPO GMP & Review: Should You Apply or Avoid?
Taurian MPS IPO GMP & Review: Should You Apply or Avoid?
Shringar House of Mangalsutra IPO GMP & Review: Apply or Avoid?
Dev Colgate Palmolive (India)elerator IPO GMP & Review: Apply or Avoid?
Related Posts
Deepak Fertilisers & Petrochemicals Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here
Dabur Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here
Cupid Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here
Why is Biocon Ltd Share Price Falling?
Karur Vysya Bank Q3 Results 2026 Highlights: Net Profit Surged by 39.10% & Revenue Up 11.84% YoY

